HIGHLIGHTS
- who: Nan Liang and collaborators from the Afufb01liated Hospital of Shandong First Medical, andNanjing Medical, China have published the research work: CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer, in the Journal: (JOURNAL)
- what: The authors identified CCKAR as a prognostic biomarker of NSCLC, and showed that CCKAR in NSCLC was significantly associated with asynchronous BM.
- how: The quantification of qRT-PCR results was analyzed by the 2-DDCt method with GAPDH as an internal control. The results indicated that patients with high CCKAR should . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.